Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study
Journal of the National Cancer Center · 2026-06 · 6 (3) · 250-258
DOI: 10.1016/j.jncc.2026.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Cancer Center, 2026-06. Verfasst von Yuanjie Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centre International de Recherche sur le Cancer, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To provide an updated global assessment of esophageal and gastric cancers incidence by histological subtype and anatomical subsite.
Methods
We utilized data from GLOBOCAN 2022 and Cancer Incidence in Five Continents Vol. XII (2013-2017) to estimate the incidence of esophageal cancer subtypes (squamous cell carcinoma [ESCC] and adenocarcinoma [EAC]) and gastric cancer subsites (cardia [CGC] and non-cardia [NCGC]). Age-standardized incidence rates (ASIRs) were calculated by sex for each country, world region, and Human Development Index (HDI) category. Spearman correlation analysis was conducted to evaluate the association between ASIRs and HDI.
Results
In 2022, an estimated 511,000 new esophageal cancer cases occurred globally (83% ESCC [ASIR 4.1 per 100,000 person-years], 16% EAC [ASIR 0.8]), with Eastern Asia accounting for 53% of global ESCC and 25% of EAC cases. Among 968,000 gastric cancer cases, 13% were CGC (ASIR 1.2 per 100,000 person-years) and 87% were NCGC (ASIR 8.0), with Eastern Asia contributing 44% and 55% of CGC and NCGC cases, respectively. Notably, age-stratified analyses revealed a distinct burden of early-onset disease (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- Centre International de Recherche sur le Cancer
- National Natural Science Foundation of China
Zitieren
APA
Zheng, Y., Tan, N., Teng, Y., Li, T., Wang, J., Wu, Y., Li, Q., Cao, M., He, S., Zuo, T., Xia, C., & Chen, W. (2026). Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study. Journal of the National Cancer Center, 6(3), 250-258. https://doi.org/10.1016/j.jncc.2026.03.005
Vancouver
Zheng Y, Tan N, Teng Y, Li T, Wang J, Wu Y, et al. Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study. Journal of the National Cancer Center. 2026;6(3):250-258. doi:10.1016/j.jncc.2026.03.005
BibTeX
@article{Zheng2026,
author = {Zheng, Yuanjie and Tan, Nuopei and Teng, Yi and Li, Tianyi and Wang, Jiachen and Wu, Yujie and Li, Qianru and Cao, Mengdi and He, Siyi and Zuo, Tingting and Xia, Changfa and Chen, Wanqing},
title = {Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study},
journal = {Journal of the National Cancer Center},
year = {2026},
volume = {6},
number = {3},
pages = {250--258},
doi = {10.1016/j.jncc.2026.03.005}
}
EUVIMED